Featured Research

from universities, journals, and other organizations

New Malaria Agent Found In Chimpanzees Close To That Commonly Observed In Humans

Date:
May 29, 2009
Source:
Public Library of Science
Summary:
Researchers based in Gabon and France report the discovery of a new malaria agent infecting chimpanzees in Central Africa. This new species, named Plasmodium gaboni, is a close relative of the most virulent human agent P. falciparum.

Researchers based in Gabon and France report the discovery of a new malaria agent infecting chimpanzees in Central Africa. This new species, named Plasmodium gaboni, is a close relative of the most virulent human agent P. falciparum.

The research is described in an article published May 29 in the open-access journal PLoS Pathogens.

P. falciparum is the major human malaria agent responsible for one to three million deaths annually. In 2002, the publication of the genome of P. falciparum generated new hopes in the fight against this deadly disease, by the opportunities it offered to discover new drug targets. However, the lack of known related genomes has limited the development of comparative genomics according to the study's researchers from Centre International de Recherches Médicales de Franceville, Centre National de la Recherche Scientifique, and l'Institut de Recherche pour le Développement.

To investigate the diversity of Plasmodium parasites circulating in chimpanzees in Africa, the team collected blood from 19 wild-borne animals kept as pets by villagers in Gabon. Two were found infected by a Plasmodium parasite. The sequencing of the parasite's whole mitochondrial genome revealed that it belonged to a previously undescribed species of Plasmodium, closely related to P. falciparum. Sequencing of the nuclear genome of this new agent should further the understanding of genomic adaptations of P. falciparum to humans and thus help discover new potential drug targets.

The development of comparative genomics to further understanding of P. falciparum has been hindered by a lack of knowledge of closely related species' genomes. Only one species, P. reichenowi, infecting chimpanzees, was previously known as a sister lineage of P. falciparum. Additional information on related species has thus been needed, making the discovery of P. gaboni an important step forward in exploring a possible relationship for malaria between chimpanzees and humans.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ollomo B, Durand P, Prugnolle F, Douzery E, Arnathau C, et al. A New Malaria Agent in African Hominids. PLoS Pathogens, 2009; 5 (5): e1000446 DOI: 10.1371/journal.ppat.1000446

Cite This Page:

Public Library of Science. "New Malaria Agent Found In Chimpanzees Close To That Commonly Observed In Humans." ScienceDaily. ScienceDaily, 29 May 2009. <www.sciencedaily.com/releases/2009/05/090528203735.htm>.
Public Library of Science. (2009, May 29). New Malaria Agent Found In Chimpanzees Close To That Commonly Observed In Humans. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/05/090528203735.htm
Public Library of Science. "New Malaria Agent Found In Chimpanzees Close To That Commonly Observed In Humans." ScienceDaily. www.sciencedaily.com/releases/2009/05/090528203735.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins